|
Volumn 32, Issue 3, 2001, Pages 432-435
|
The challenge and opportunity of new clinical infectious entities
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
GAMMA INTERFERON RECEPTOR;
IMMUNOSUPPRESSIVE AGENT;
PROTEIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BACTERIAL VIRULENCE;
CLINICAL FEATURE;
DISEASE PREDISPOSITION;
GENOTYPE;
HUMAN;
IMMUNE RESPONSE;
INFECTION;
LUNG DISEASE;
MORTALITY;
MYCOBACTERIOSIS;
MYCOBACTERIUM ABSCESSUS;
MYCOBACTERIUM AVIUM;
MYCOBACTERIUM CHELONEI;
NONHUMAN;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
PULSED FIELD GEL ELECTROPHORESIS;
REVIEW;
ANIMALS;
COMMUNICABLE DISEASES, EMERGING;
HUMANS;
MICE;
MYCOBACTERIA, ATYPICAL;
MYCOBACTERIUM INFECTIONS, ATYPICAL;
VIRULENCE;
|
EID: 0035109792
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/318507 Document Type: Review |
Times cited : (2)
|
References (22)
|